Following the FDA’s approval of A 150mg version of Accord’ Herceptin biosimilar, the US agency has now greenlit a higher 400mg strength version of the rival.
The US Food and Drug Administration has approved Accord BioPharma’s 420mg strength Herceptin (trastuzumab) biosimilar Hercessi as a treatment for HER-2 overexpressing breast and gastric or gastroesophageal junction adenocarcinoma, adding to the past approval of the drug’s 150mg formulation earlier this year.
The approval of the 150mg version of the biosimilar earlier this year in April marked the FDA’s 50th biosimilar approval,...
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
This article compiles all of the data from Generics Bulletin’s 2024 ranking of the Top 50 firms across the generics and biosimilars industry, including additional details of how the various financial figures stack up.
